Company intelligence / Profile preview

Dalriada Drug Discovery

Mississauga / Toronto area / GTA (“Greater Toronto Area”), Ontario, Canadadalriadatx.com ↗

Ownership: Private
Employees: ~100
Development stage: Preclinical

Overview

Dalriada Drug Discovery provides integrated small molecule drug discovery services as a CRO. It specializes in challenging and undruggable targets using proprietary proteomics and chemoproteomics platforms. The company does not have its own clinical pipeline but has enabled major milestones for clients, including IPOs and large pharma collaborations.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Drug Discovery Services

Partnerships

Canopy Growth (NCE pipeline creation)Antibe Therapeutics [program continuation with OCT]Supported Medicxi-funded Janpix’s program leading to Centessa Pharmaceuticals IPOSupported Dunad’s collaboration with Novartis

Beyond the preview

Go deeper on Dalriada Drug Discovery.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dalriada Drug Discovery.

Explore the full profile